Gupta Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Gupta Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$14K	Buy	180 +147	+445%	+$13.3K	﹤0.01%	790
2015 Q4	$4K	Hold	33	–	–	﹤0.01%	1060
2015 Q3	$3K	Hold	33	–	–	﹤0.01%	1108
2015 Q2	$4K	Sell	33 -37	-53%	-$4.66K	﹤0.01%	1052
2015 Q1	$8K	Buy	+70	New	+$8.39K	﹤0.01%	812

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Gupta Wealth Management's VRTX Position: Q1 2016 in Review

Gupta Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 445% in Q1 2016, buying an estimated $13.3K and bringing the position to 180 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #790.

Gupta Wealth Management first reported a position in VRTX in Q1 2015 and has held it in 5 quarters since. 503 funds tracked by Wall St. Rank hold VRTX as of Q1 2016.

Gupta Wealth Management held 180 shares of Vertex Pharmaceuticals worth $14K as of Q1 2016.
Gupta Wealth Management bought 147 Vertex Pharmaceuticals shares in Q1 2016, an estimated $13.3K.
Vertex Pharmaceuticals made up ﹤0.01% of Gupta Wealth Management's portfolio in Q1 2016, its #790 holding.
Gupta Wealth Management first reported a position in Vertex Pharmaceuticals in Q1 2015 and has held it in 5 quarters since.
503 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2016.

Based on Gupta Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.